Pradofloxacin
CAS 195532-12-8 - Third-Generation Fluoroquinolone Antibiotic for Animal Health
Pradofloxacin Veterinary API is a third-generation fluoroquinolone antibiotic developed exclusively for veterinary use. It is primarily used to treat bacterial infections in companion animals, especially cats and dogs. Pradofloxacin acts by inhibiting bacterial DNA synthesis, effectively preventing bacterial growth and replication.
Pradofloxacin is valued for its broad-spectrum antibacterial activity and is commonly used in veterinary formulations where treatment reliability and resistance management are critical. This API is not approved for human use.
Product Overview & Specifications
Pradofloxacin
195532-12-8
Veterinary Pharmaceutical API - In-house standard
C₂₁H₂₁FN₄O₃
396.41
246–248 °C
Powder, white to almost white
Each batch is supplied with appropriate quality documentation to support formulation development and regulatory review.
Veterinary Applications of Pradofloxacin
Pradofloxacin belongs to the fluoroquinolone class of antibiotics and exhibits strong activity against a wide range of Gram-positive and Gram-negative bacteria. It is primarily used to treat bacterial infections in cats and dogs, including:
▸ Respiratory tract infections
▸ Urinary tract infections (UTIs)
▸ Skin and soft tissue infections
Due to its potency and spectrum of activity, Pradofloxacin is often selected as a second-line treatment when first-line antibiotics are ineffective or when the infection shows resistance to other antimicrobial classes.
Mechanism of Action
Pradofloxacin works by inhibiting key bacterial enzymes involved in DNA synthesis and replication, ultimately leading to bacterial cell death.
Responsible Use in Veterinary Medicine
As with all antibiotics, Pradofloxacin should be used under veterinary supervision and administered at the prescribed dosage and duration. Responsible use helps to:
▸ Maximize therapeutic effectiveness
▸ Minimize adverse effects
▸ Reduce the risk of antibiotic resistance
Manufacturing & Quality Assurance
Origin operates high-standard GMP manufacturing facilities supported by a comprehensive quality management system compliant with ICH Q7. Our in-house QC laboratories are equipped with advanced analytical instrumentation to ensure consistent product quality and batch-to-batch reliability.
Customer & Procurement Information
Competitive pricing and discounts available for large-volume orders.
MOQ varies by product. Please contact us with your specific requirements for confirmation.
Evaluation and small-quantity orders are acceptable and encouraged for initial testing.
We accept T/T and L/C.
Summary
Pradofloxacin Veterinary API is a proven, broad-spectrum fluoroquinolone antibiotic for the treatment of bacterial infections in cats and dogs. With GMP-compliant manufacturing, consistent quality, and flexible procurement options, it is a reliable choice for veterinary pharmaceutical formulation and production.
Concerning Origin Biotech
Origin Biotech is committed to providing premium bioactive components and technologically sound insights with scientific validation for use in pharmaceutical, nutraceutical, and research applications. Our Knowledge platform provides professionals with trustworthy, lucid information about compounds like Pradofloxacin Veterinary API.
Interested in Pradofloxacin for Product Development or R&D?
We are able to offer:
To find out how Pradofloxacin Veterinary API can support your next companion animal health program, get in touch with our team.
Hot Tags: pradofloxacin cas 195532-12-8, China pradofloxacin cas 195532-12-8 manufacturers, suppliers, factory, 138261-41-3, Toceranib, Maropitant, 74150-27-9, Pimobendan, 356068-94-5











